文献速递主动脉疾病

夹层后胸腹主动脉瘤窄真腔患者行开窗分支腔内修复的结局:国际多中心NADIR注册研究

Postdissection thoracoabdominal aortic aneurysm presenting with narrow true lumen: Outcomes after fenestrated and branched endovascular repair from the international multicenter NArrow-true-lumen DIssection Registry (NADIR) study group.
PubMed 文献 · J Vasc Surg · 2026-06-12

基于国际多中心NADIR注册研究(2015-2025年,23中心,544例)分析夹层后胸腹主动脉瘤患者行开窗分支腔内修复的结局。80%患者存在窄真腔(真腔直径<25 mm),窄真腔增加手术复杂度但不影响技术成功率、30天死亡率和主要不良事件。窄真腔患者5年免于主动脉不良事件率较低(73% vs 91%),主要因二次假腔栓塞干预;真腔直径<10 mm是靶血管不稳定的危险因素,桥接支架加固可能有益。

要点

  • 夹层后胸腹主动脉瘤开窗分支腔内修复患者中80%存在窄真腔。
  • 窄真腔不增加30天死亡率或主要不良事件,但5年再干预率更高。
  • 真腔直径<10 mm是靶血管不稳定的独立危险因素。

核心结论

  • 窄真腔是夹层后胸腹主动脉瘤最常见的解剖表现,与更复杂的手术相关,但不影响技术成功率、死亡率和主要不良事件。
  • 窄真腔患者再干预率更高,主要为假腔栓塞。
  • 真腔直径<10 mm是靶血管不稳定的危险因素,桥接支架加固可能有益。

研究设计与样本

  • 国际多中心注册研究,纳入2015-2025年间23个中心接受开窗分支腔内修复的夹层后胸腹主动脉瘤患者544例(1705条靶血管)。
  • 窄真腔定义为术前CT血管造影显示任一主动脉平面真腔直径<25 mm。
  • 比较窄真腔与非窄真腔患者的短期和中期结局。

主要发现

  • 544例患者中438例(80%)存在窄真腔。
  • 窄真腔患者更常接受桥接支架加固(P<.001)和肾内分支(P=.038),更常行隔膜切开或假腔封堵(27% vs 11%;P=.006)。
  • 窄真腔患者手术时间更长(P=.031)、透视时间更长(P=.007)、剂量面积乘积更高(P=.046)。
  • 两组技术成功率均为95%(P=.750),总体30天死亡率为4%,主要不良事件发生率为35%,窄真腔对主要不良事件无显著影响(调整OR 0.84;95%CI 0.28-2.76;P=.766)。
  • 窄真腔患者5年免于任何主动脉不良事件率较低(73% vs 91%;P=.027),主要因二次假腔栓塞手术(P=.027)。

关键数值与推荐

  • 窄真腔定义为真腔直径<25 mm。
  • 真腔直径<10 mm与靶血管不稳定显著相关(HR 2.45;95%CI 1.37-4.36;P=.002)。
  • 使用内分支(HR 0.11;95%CI 0.02-0.87;P=.035)和桥接支架加固(HR 0.54;95%CI 0.31-0.96;P=.038)为保护因素。

临床怎么用

  • 对夹层后胸腹主动脉瘤窄真腔患者行开窗分支腔内修复时,应预期手术时间延长和复杂度增加。
  • 真腔直径<10 mm的患者可考虑桥接支架加固以降低靶血管不稳定风险。
  • 窄真腔患者术后需密切监测,因再干预(尤其假腔栓塞)风险较高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The impact of a narrow true lumen (NTL) on the outcomes of fenestrated-branched endovascular repair in patients with postdissection thoracoabdominal aortic aneurysms (PD-TAAAs) is underreported. METHODS: Data from an international, multicenter registry were analyzed, to identify patients treated for PD-TAAAs (2015-2025) at 23 centers. All patients underwent fenestrated-branched endovascular repair using custom or off-the-shelf endografts. NTL was defined by a true lumen diameter <25 mm identified at any aortic level on preoperative computed tomography angiogram. Short-term endpoints compared between NTL and no-NTL patients included technical success, procedural metrics, 30-day mortality, and major adverse events (MAEs). Midterm endpoints included 5-year freedom from aortic adverse events (related mortality, rupture, reintervention, endograft instability) and freedom from target artery instability. RESULTS: Among 544 patients (1705 target vessels), 438 (80%) had an NTL. Device design did not differ between groups (52% branches, 30% fenestrated, and 18% fenestrated-branched combination; P = .053). Patients with an NTL more frequently received bridging stent reinforcement (P < .001), and renal inner branches (P = .038). Septotomy or false lumen occlusion were more often performed in NTLs (27% vs 11%; P = .006). Patients with NTLs had longer operating time (P = .031), fluoroscopy time (P = .007), and a higher dose area product (P = .046). Technical success was 95% in both groups (P = .750). Overall 30-day mortality was 4%, and MAEs occurred in 35%. NTLs did not have a significant impact on MAEs (adjusted odds ratio, 0.84; 95% confidence interval [CI], 0.28-2.76; P = .766). Freedom from any aortic adverse event at 5 years was lower in patents with NTL (73% vs 91%; P = .027), driven primarily by secondary procedures of false lumen embolization (P = .027). Freedom from target vessel instability was 86% ± 4% in the NTL group and 92% ± 4% in the no-NTL group (P = .072). Patients with NTLs had a similar primary patency (97% ± 2% vs 98% ± 2%; P = .380) but lower freedom from target vessel endoleak (89% ± 4% vs 97% ± 3%; P = .006). After adjustment, NTL diameter <10 mm (hazard ratio [HR], 2.45; 95% CI, 1.37-4.36; P = .002) was significantly associated with target artery instability. Use of inner branches (HR, 0.11; 95% CI, 0.02-0.87; P = .035) and bridging stent reinforcement (HR, 0.54; 95% CI, 0.31-0.96; P = .038) were protective. CONCLUSIONS: NTL is the most common anatomic presentation in PD-TAAAs and is associated with more complex procedures, but does not affect technical success, mortality, or MAEs. Patients with an NTL experience a higher rate or reinterventions, primarily false lumen embolization. NTL <10 mm is a risk factor for target vessel instability, and reinforcement of bridging stents may be beneficial in these cases.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Piazza M, Marrocco S, Kölbel T, et al. Postdissection thoracoabdominal aortic aneurysm presenting with narrow true lumen: Outcomes after fenestrated and branched endovascular repair from the international multicenter NArrow-true-lumen DIssection Registry (NADIR) study group. J Vasc Surg. 2026. PMID: 42285180. doi:10.1016/j.jvs.2026.04.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。